| The Diabetes TeleCare Study (NCT00288132) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-09-01 |
| NovoLet® Acceptance Study Within the Hospital Practise in Indonesia (NCT01492205) | Novo Nordisk A/S | 2005-09-01 |
| Lantus Effect on Myocardial Glucose Metabolism in T2 (NCT00335465) | Sanofi | 2005-09-01 |
| A Study In Patients With Type 2 Diabetes Mellitus (NCT00256867) | GlaxoSmithKline | 2005-08-18 |
| Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone (NCT00121667) | AstraZeneca | 2005-08-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 Diabetes (NCT02183415) | Boehringer Ingelheim | 2005-08-01 |
| Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function (NCT01508806) | Novo Nordisk A/S | 2005-08-01 |
| Trial of New Dietary Treatment of Diabetes (NCT00128089) | Manassas Internal Medicine | 2005-08-01 |
| The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort (NCT03356262) | St. Justine's Hospital | 2005-07-25 |
| Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED) (NCT00423488) | Organon and Co | 2005-07-12 |
| Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise (NCT00121641) | AstraZeneca | 2005-07-01 |
| US Inhaled Insulin Therapeutic Choice Questionnaire Study (NCT00139763) | Pfizer | 2005-07-01 |
| Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes (NCT00184561) | Novo Nordisk A/S | 2005-07-01 |
| Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe (NCT00127296) | Novo Nordisk A/S | 2005-07-01 |
| Hospital In-Patient Insulin Study (NCT00135070) | The Royal Bournemouth Hospital | 2005-07-01 |
| Ontario Printed Educational Materials (PEMs) for Physician Behaviour Change (NCT00210275) | Institute for Clinical Evaluative Sciences | 2005-07-01 |
| Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes (NCT00120536) | Novartis | 2005-06-01 |
| A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus (NCT00212641) | Ono Pharma USA Inc | 2005-06-01 |
| Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) (NCT00296296) | Stanford University | 2005-06-01 |
| Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation (NCT00182026) | McMaster University | 2005-06-01 |
| A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes (NCT00111670) | Hoffmann-La Roche | 2005-06-01 |
| Stepping Up to Health: Feedback to Promote Physical Activity in Diabetes (NCT00151021) | University of Michigan | 2005-06-01 |
| A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump (NCT00115973) | Novo Nordisk A/S | 2005-06-01 |
| Exercise Training for Patients With Poor Leg Circulation (NCT00118560) | US Department of Veterans Affairs | 2005-06-01 |
| Improving Blood Pressure Management in Patients With Diabetes (NCT00374270) | University of Alberta | 2005-05-01 |
| Retinal Function in Diabetic Patients Without Retinopathy (NCT00839150) | Assistance Publique - Hôpitaux de Paris | 2005-05-01 |
| MATCH: The Mexican-American Trial of Community Health Workers (NCT01067092) | Rush University Medical Center | 2005-05-01 |
| Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes (NCT00184613) | Novo Nordisk A/S | 2005-05-01 |
| An Intervention Program to Control Diabetes (NCT00543621) | Abbott Nutrition | 2005-05-01 |
| A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes (NCT00111631) | Hoffmann-La Roche | 2005-05-01 |
| Insulin Glargine During and After the Period of Fasting in Ramadan (NCT00258804) | Sanofi | 2005-05-01 |
| A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes (NCT00351507) | Novartis Pharmaceuticals | 2005-05-01 |
| Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary Care (NCT01049737) | Linkoeping University | 2005-05-01 |
| A New Oral Treatment For Type II Diabetes Mellitus (NCT00111800) | GlaxoSmithKline | 2005-04-28 |
| Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy (NCT00108485) | University of Miami | 2005-04-01 |
| Insulin Glargine in Type 2 Diabetes Mellitus (NCT00272077) | Sanofi | 2005-04-01 |
| Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia (NCT00462046) | Shanghai Jiao Tong University School of Medicine | 2005-04-01 |
| Evaluating the Use of Two Different Needles in Subjects With Diabetes (NCT00569426) | Novo Nordisk A/S | 2005-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes (NCT02183350) | Boehringer Ingelheim | 2005-04-01 |
| A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects (NCT00162305) | AstraZeneca | 2005-04-01 |
| Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes (NCT00184574) | Novo Nordisk A/S | 2005-04-01 |
| Internet Intervention to Improve Rural Diabetes Care (NCT00403091) | University of Alabama at Birmingham | 2005-04-01 |
| Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes (NCT00504673) | Novo Nordisk A/S | 2005-04-01 |
| Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes (NCT00110240) | Novartis Pharmaceuticals | 2005-04-01 |
| Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes (NCT00106366) | Novo Nordisk A/S | 2005-03-01 |
| Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (NCT00646542) | Novartis | 2005-03-01 |
| Local Registration Trial in China Humalog Mix 50 (NCT00191581) | Eli Lilly and Company | 2005-03-01 |
| Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035) (NCT00106704) | Merck Sharp & Dohme LLC | 2005-03-01 |
| Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome (NCT00243984) | Northeastern Ohio Universities College of Medicine | 2005-03-01 |
| Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes (NCT00106340) | Novartis Pharmaceuticals | 2005-03-01 |
| GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus (NCT00226330) | AstraZeneca | 2005-03-01 |
| A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes (NCT00351546) | Novartis | 2005-02-01 |
| GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes (NCT00229710) | AstraZeneca | 2005-02-01 |
| Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes (NCT00104182) | Novo Nordisk A/S | 2005-02-01 |
| Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride (NCT00424762) | University of Texas Southwestern Medical Center | 2005-02-01 |
| A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery Disease (NCT00248352) | Ottawa Heart Institute Research Corporation | 2005-02-01 |
| Eze/Simva Switch Study in Diabetics (0653A-807) (NCT00541697) | Organon and Co | 2005-01-19 |
| Surveillance Study of NovoRapid® for New Drug Re-examination (NCT01490112) | Novo Nordisk A/S | 2005-01-01 |
| New Body Mass Index (BMI) Cut-offs for the Diagnosis of Obesity and Comorbidities (NCT01055626) | Clinica Universidad de Navarra, Universidad de Navarra | 2005-01-01 |
| Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes (NCT00138567) | Novartis | 2005-01-01 |
| Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes (NCT00101803) | Novartis Pharmaceuticals | 2005-01-01 |
| Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care (NCT00435240) | Lund University Hospital | 2005-01-01 |
| Study of Improving Insulin Sensitivity by Electroacupuncture Therapy (NCT00379379) | China Medical University Hospital | 2005-01-01 |
| Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes (NCT00263419) | Heidelberg University | 2005-01-01 |
| Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes (NCT00097877) | Novo Nordisk A/S | 2005-01-01 |
| Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes (NCT00154414) | Novo Nordisk A/S | 2005-01-01 |
| Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes (NCT00102466) | Novartis Pharmaceuticals | 2005-01-01 |
| Evaluation of Effect of Exercise on Prescription (NCT00399997) | University of Southern Denmark | 2005-01-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00154401) | Novo Nordisk A/S | 2005-01-01 |
| Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes (NCT00102388) | Novartis Pharmaceuticals | 2005-01-01 |
| Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes (NCT00138606) | Novartis | 2005-01-01 |
| Opposing Step-by-step Insulin Reinforcement to Intensified Strategy (NCT00174642) | Sanofi | 2004-12-01 |
| Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart (NCT00494988) | Novo Nordisk A/S | 2004-12-01 |
| Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes (NCT00332488) | Mannkind Corporation | 2004-12-01 |
| Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP) (NCT00099515) | Eli Lilly and Company | 2004-11-01 |
| Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes (NCT00184600) | Novo Nordisk A/S | 2004-11-01 |
| Insulin Glulisine in Diabetes Mellitus, Type 2 (NCT00174668) | Sanofi | 2004-11-01 |
| To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. (NCT00143338) | Pfizer | 2004-11-01 |
| Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes (NCT00138515) | Novartis | 2004-11-01 |
| Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes (NCT00138580) | Novartis | 2004-11-01 |
| Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes (NCT00138619) | Novartis | 2004-11-01 |
| Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes (NCT00138554) | Novartis | 2004-11-01 |
| Jikei Optimal Insulin Therapy in Type 2 Diabetes (NCT00348231) | Jikei University School of Medicine | 2004-11-01 |
| Effects of Exercise Therapy on Ventricular and Endothelial Function in Patients After Coronary Artery Bypass Surgery (NCT01990638) | National Taiwan University Hospital | 2004-11-01 |
| Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea (NCT00328965) | GlaxoSmithKline | 2004-11-01 |
| An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications (NCT02678676) | Takeda | 2004-11-01 |
| An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023) (NCT00094757) | Merck Sharp & Dohme LLC | 2004-10-06 |
| INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study (NCT00101751) | Novo Nordisk A/S | 2004-10-01 |
| Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes (NCT00138541) | Novartis | 2004-10-01 |
| Olmesartan Medoxomil in Diabetes Mellitus (NCT00185159) | Sankyo Pharma Gmbh | 2004-10-01 |
| Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina (NCT01387165) | GlaxoSmithKline | 2004-10-01 |
| Noninvasive Skin Spectroscopy for Diabetes Screening (NCT00358254) | InLight Solutions | 2004-10-01 |
| Moderate Alcohol Consumption, Fat and Carbohydrate Metabolism and Insulin Sensitivity (NCT00364767) | TNO | 2004-10-01 |
| Eye on Diabetes: A Multidisciplinary Patient Education Intervention (NCT00417924) | Nova Southeastern University | 2004-10-01 |
| An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) (NCT00095056) | Merck Sharp & Dohme LLC | 2004-10-01 |
| Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia (NCT00101712) | Novartis Pharmaceuticals | 2004-10-01 |
| Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. (NCT00184626) | Novo Nordisk A/S | 2004-09-10 |
| HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population (NCT00600236) | Asociación para Evitar la Ceguera en México | 2004-09-01 |
| Post Marketing Surveillance Study of Biphasic Insulin Aspart 30 (NCT01536613) | Novo Nordisk A/S | 2004-09-01 |
| Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes (NCT00097084) | Novo Nordisk A/S | 2004-09-01 |